Key result
Deep learning advances cardiac anomaly detection, though data rarity and inconsistent evaluation constrain performance.
Why the study?
Heart disease remains a leading cause of mortality, making effective detection methods essential as techniques evolve from clinical settings to wearable and remote sensing technologies.
This comprehensive review provides a structured taxonomy of deep learning tasks for heart disease anomaly detection and highlights the critical performance gaps between clinical and wearable sensor data.
Barriers to reliable anomaly detection may constrain wearable integration into practice; leaves open the value of standardized benchmarks for advancing deep learning in cardiology.
Heart disease is a prevalent concern for individuals in every age group, as it significantly impacts their health and remains a leading cause of mortality today. An effective heart disease detection method is essential for people to assess their heart conditions accurately. Over the past decades, heart disease detection techniques, whether based on machine learning or deep learning, have evolved considerably—from relying on handcrafted features to automatically learned features, from using single models to hybrid models and from applications confined to clinical settings to deployment in daily life through wearable and remote sensing technologies. This paper provides a comprehensive review of various types of heart-related data and popular deep learning algorithms employed for heart disease detection. In addition, we conduct a comparative experiment that showcases the existing gaps between clinical and wearable signals and highlights the potential for further research on wearable devices. This paper also identifies the key challenges, emphasises the primary factors affecting detection performance and discusses potential solutions.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted a review in Heart disease. Deep learning algorithms was evaluated. Deep learning algorithms for heart disease anomaly detection have evolved considerably, though performance remains constrained by data rarity, annotation reliability, and evaluation inconsistencies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: